Search the Newsreel

Enterprise value to EBITDA forward of Roadzen, Inc. – NASDAQ:RDZNW

This article presents financial information for Roadzen, Inc. (NASDAQ: RDZNW), specifically focusing on its enterprise value to EBITDA forward. It indicates the stock market and provides a brief statement about data sources. The content itself is very minimal, serving more as a heading within …

Jiangsu Zenergy Battery Technologies 1H 2025 Net Was CNY220.0M>3677.HK

How (CZFS) Movements Inform Risk Allocation Models

This article analyzes Citizens Financial Services Inc. (NASDAQ: CZFS) using AI models to inform risk allocation. It highlights strong sentiment supporting an overweight bias, notes the absence of resistance above the current price, and outlines three distinct trading strategies (Position Trading, Momentum Breakout, Risk …

Citizens Financial Services (NASDAQ:CZFS) Cut to "Hold" at Wall Street Zen

Wall Street Zen downgraded Citizens Financial Services (CZFS) from "Buy" to "Hold," despite the company beating quarterly earnings and revenue expectations. Other analyst opinions were mixed, with Weiss Ratings upgrading and Zacks Research downgrading the stock. Institutional investors hold a significant portion of CZFS …

Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues

Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into Azenta, Inc. (AZTA) on behalf of investors who lost money. The investigation follows Azenta's Q2 2026 financial results, which missed consensus estimates and led to a significant stock price drop after …

Citizens (CIA) Stock Sinks After Profit Turns To Loss

Citizens (CIA) stock dropped significantly after its Q2 2026 earnings report revealed a shift from profit to a small loss, contradicting previous investor expectations of improving profitability. Revenue declined year-on-year, and the net profit margin softened, reinforcing bearish arguments and raising concerns about the …

Surrozen Inc (SRZN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Surrozen Inc (SRZN) has an earnings forecast score of 8.40, placing it 132nd in the Biotechnology & Medical Research industry. Analysts have an average price target of $37.00 for SRZN, with a "Buy" trend based on 5 analysts. The company's expected revenue for the …

AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. SOPHiA GENETICS and AstraZeneca (LSE:AZN) have entered a global partnership to develop and launch two decentralized companion diagnostics in precision oncology. The multi-year collaboration focuses on clinical …

CITIZENS & NORTHERN CORP Q2 2026: Revenue $41.57M, EPS $0.79— 10-Q Summary

CITIZENS & NORTHERN CORP (CZNC) reported a strong second quarter for 2026, with revenue reaching $41.57M and EPS at $0.79. This significant year-over-year growth was primarily fueled by increased interest income and contributions from the October 2025 Susquehanna acquisition. The company saw substantial increases …

Citizens Financial Services (CZFS) Stock Faces Credit Scrutiny Despite Stronger Profit Growth

Citizens Financial Services (CZFS) saw its stock dip by 2.3% despite reporting stronger profit growth, with Q2 2026 revenue up 9.9% and net income up 20.4% year-over-year. The market's reaction is attributed to concerns over the company's credit quality, specifically a rise in non-performing …

Wedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating

Wedbush has adjusted its price target for Zentalis Pharmaceuticals (ZNTL) to $5, an increase from the previous $4. The firm has decided to maintain its Neutral rating on the company's stock. This change reflects Wedbush's updated valuation for Zentalis Pharmaceuticals.

Citizens & Northern Earnings Top Estimates on Revenue of $39.7 Million

Citizens & Northern Corp. (CZNC) reported strong second-quarter results, with net income of $14.1 million (79 cents per share) and revenue net of interest expense reaching $39.7 million, surpassing Street forecasts. The bank holding company, headquartered in Wellsboro, Pennsylvania, saw its total revenue, including …

First Citizens BancShares, Inc. $FCNCA Stock Position Lifted by Reinhart Partners LLC.

Parallel Advisors LLC Purchases New Position in Astrazeneca Plc $AZN

Parallel Advisors LLC has acquired a new position in AstraZeneca Plc, purchasing 8,718 shares valued at approximately $1.72 million in the first quarter. This comes as institutional investors collectively own 20.35% of AstraZeneca, and analysts maintain a "Moderate Buy" consensus rating with an average …

161,624 Shares in Astrazeneca Plc $AZN Acquired by Professional Advisory Services Inc.

Professional Advisory Services Inc. recently acquired 161,624 shares of AstraZeneca Plc (NYSE:AZN) for approximately $30.2 million, making it their seventh-largest holding. AstraZeneca reported strong quarterly earnings, beating EPS estimates, and analysts maintain a "Moderate Buy" rating for the stock. The company's financial performance and …

Roadzen Inc (RDZN) Stock News Today

This article provides an update on Roadzen Inc (RDZN) stock news, earnings, analyst ratings, and key developments. As of the close on August 7, the stock was trading at $1.330, up 7.26%. The platform notes that more news is expected soon regarding RDZN.

Empowered Funds LLC Sells 1,211 Shares of First Citizens BancShares, Inc. $FCNCA

Análise e Previsão das Ações da AstraZeneca PLC (AZN)

Citizens (NYSE:CIA) Issues Earnings Results, Misses Expectations By $0.06 EPS

AstraZeneca Pharma India secures CDSCO approval for Enhertu in new breast cancer use

Jefferies Reaffirms Their Buy Rating on AstraZeneca (AZN)

Zentalis Highlights Q2 Results and Azenosertib Progress

Zentalis Pharmaceuticals reported its Q2 2026 results and provided an update on the progress of azenosertib, its drug for Cyclin E1-positive platinum-resistant ovarian cancer. The company maintains a cash runway into late 2027 and is advancing its DENALI trial, aiming for an integrated topline …

AstraZeneca PLC Stock 12‑Month Price Target Raised to $216.47, Implies 34% Upside

AstraZeneca PLC's average 12-month price target has been increased to $216.47, up from $215.03, according to 26 analysts. This updated target suggests a potential upside of approximately 34% based on the August 6 closing price. The consensus rating from 31 analysts remains a "Buy," …

Noticias de acciones de AstraZeneca PLC (AZN)

Zentek Ltd (ZTEK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Zentek Ltd (ZTEK), detailing future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a peer comparison with other biotechnology and medical research companies. The financial forecasting section covers EPS, Revenue, and Net …

Zenatech Inc (ZENA-Q) Stock Price and News

This article provides real-time stock information for Zenatech Inc. (ZENA-Q), detailing its recent stock performance, trading data, and company news. Key updates include Zenatech's expansion of its U.S. Drone as a Service network with acquisitions in Ohio and Idaho, strengthening its offerings for government …

ZenaTech (ZENA) Extends DaaS Reach With Patents And Deals

ZenaTech (ZENA) has significantly expanded its Drone-as-a-Service (DaaS) reach through strategic acquisitions and new patent filings. The company acquired Velocity Geomatics, its 25th acquisition, to deepen its presence in the Canadian oil & gas environmental and regulatory DaaS sector, and BA Land Professionals, its …

Citizens & Northern (CZNC) Earnings Date and Reports 2026

Citizens & Northern (CZNC) reported Q2 2026 earnings on August 7, 2026, beating consensus estimates with an EPS of $0.79 and revenue of $39.65 million. The company's earnings are projected to grow by 26.73% next year. The next earnings report is estimated for August …

Roadzen Inc (RDZN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Roadzen Inc (RDZN), highlighting its current earnings forecast score of 8.00 and an average price target of $5.00 based on analysis from two analysts. It details expected future revenue and EPS, noting that analysts generally recommend a …

Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP

Quantinno Capital Management LP significantly reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 63.3% in the first quarter, selling over 391,000 shares and retaining 226,690 shares valued at approximately $4.79 million. Despite this, Azenta recently surpassed quarterly earnings expectations, reporting an adjusted EPS of …

Zentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.44, Implies 49% Upside

Analysts have raised the average 12-month price target for Zentalis Pharmaceuticals, Inc. (ZNTL) stock to $7.44, up from $7.22, with individual forecasts ranging from $4 to $11 per share. This updated target suggests a potential upside of approximately 49% from the August 6th closing …

ZenaTech (ZENA) Extends Drones-as-a-Service Reach With Patent Push

ZenaTech (ZENA) has announced a significant expansion of its Drones-as-a-Service (DaaS) reach through acquisitions and a patent push. The company completed its 25th and 26th DaaS deals, expanding its presence in Canadian oil and gas environmental services and across 12 U.S. states in construction, …

ZENA Stock Pops As ZenaTech Expands Drone-Services Empire

ZenaTech Inc. (ZENA) stock surged by 15.4% following an AI partnership announcement and a series of strategic acquisitions. The company completed its 25th and 26th deals, expanding its Drone-as-a-Service (DaaS) footprint in Canadian oil & gas and U.S. construction, infrastructure, energy, and public works …

Empowered Funds LLC Buys 22,484 Shares of Citizens Financial Group, Inc. $CFG

Empowered Funds LLC significantly increased its stake in Citizens Financial Group, Inc. (NYSE:CFG) by 182.9% in the first quarter, acquiring an additional 22,484 shares to bring its total holdings to 34,775 shares valued at approximately $2.1 million. The article highlights that institutional investors own …

Surrozen (SRZN) warrants expiring 2026 removed from Nasdaq listing

Surrozen, Inc. (SRZN) warrants expiring on August 10, 2026, have been delisted from the Nasdaq Stock Market LLC. This removal was processed under Section 12(b) of the Securities Exchange Act of 1934, following Nasdaq's and SEC's rules. The delisting signifies that the warrants will …

Surrozen (NASDAQ:SRZN) Issues Quarterly Earnings Results, Beats Expectations By $0.88 EPS

Surrozen (NASDAQ:SRZN) announced its quarterly earnings, reporting an EPS loss of $0.41, significantly better than the consensus estimate of ($1.29), and revenue of $5.00 million, surpassing expectations. Despite beating earnings, the stock declined by $0.31 to $21.64. Analysts maintain a "Moderate Buy" rating, but …